This product is contraindicated in individuals who have shown hypersensitivity to its components. It is also contraindicated in patients with acute myocardial infarction, hypotension and in lactating women.
Doxofylline is indicated for the treatment of bronchial asthma and pulmonary disease with spastic bronchial component.
Explore more products from our portfolio
